Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-lactam Infusion Strategies and Combination Therapy in Sepsis
NCT05681442Phase 4Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2023
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in sepsis (4 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: 30-day mortality and Major Adverse Kidney Events within 30 days. Started Nov 2023; status: active, not recruiting.
02
Conditions
sepsis
Beyond the preview
Go deeper on NCT05681442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05681442.